Archives for May 30, 2006

← 2006

Engelhard set to fall in BASF's hands

By  Gregory Roumeliotis

The stage is ready for the biggest acquisition in BASF's 140-year history after Engelhard's management agreed to recommend their shareholders accept the German chemical group's $5bn (€3.8bn) takeover bid.

Regulatory affairs just got easier

By  Kirsty Barnes

Those in the regulatory affairs profession can now breathe a sigh of relief as the industry-recognised accreditation process just got a whole lot easier.

New particle counter 'longest lasting available'

By  Gregory Roumeliotis

Particle Measuring Systems have fitted its portable airborne-particle counter with what it claims is the longest lasting laser on the market, as well as new features that allow it to calculate and create reports for EC GMP Annex #1, ISO 14644-1, and...

Sigma-Aldrich introduces signal transduction protein array

By  Wai Lang Chu

Sigma-Aldrich introduces its signal transduction protein array for high-throughput functional screening, which is set to play a major role in identifying proteins that are involved in cellular processes including proliferation, differentiation and...

Opportunities in gastrointestinal R&D

By  Kirsty Barnes

The gastrointestinal (GI) market is one of the largest in the pharma industry and continues to attract a high level of R&D investment, however, the market has recently entered a crucial phase, with mounting commercial pressures causing drug developers...

Unique sterile manufacturing facility opens in Kentucky

By  Gregory Roumeliotis

The University of Kentucky has unveiled the state's largest sterile pharmaceutical manufacturing site which is unique among others worldwide as it is the first to produce cytotoxic and non-cytotoxic drugs in the same room at the same time.

AstraZeneca's R&D investment in China 'the largest yet'

By  Gregory Roumeliotis

In what it claims is the largest investment to date by any multinational drug company in China, AstraZeneca will spend $100m (€77.6m) on research and development in the country over the next three years, targeting primarily the domestic market.

Cardinal pioneers first-of-its-kind RFID pilot

By  Kirsty Barnes

Cardinal Health is about to embark on a first-of-its-kind radiofrequency identification (RFID) tag pilot that tests the viability of the new technology across the entire supply chain, from item throughout to case and pallet level.